These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

185 related items for PubMed ID: 16021908

  • 1. Sequence analysis of the 5'-flanking regions of human dihydropyrimidine dehydrogenase gene: identification of a new polymorphism related with effects of 5-fluorouracil.
    Hasegawa T, Kim HS, Fukushima M, Wataya Y.
    Nucleosides Nucleotides Nucleic Acids; 2005; 24(4):233-42. PubMed ID: 16021908
    [Abstract] [Full Text] [Related]

  • 2. Aberrant methylation of DPYD promoter, DPYD expression, and cellular sensitivity to 5-fluorouracil in cancer cells.
    Noguchi T, Tanimoto K, Shimokuni T, Ukon K, Tsujimoto H, Fukushima M, Noguchi T, Kawahara K, Hiyama K, Nishiyama M.
    Clin Cancer Res; 2004 Oct 15; 10(20):7100-7. PubMed ID: 15501990
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Dihydropyrimidine dehydrogenase: a tumoral target for fluorouracil modulation.
    Fischel JL, Etienne MC, Spector T, Formento P, Renée N, Milano G.
    Clin Cancer Res; 1995 Sep 15; 1(9):991-6. PubMed ID: 9816071
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Thymidylate synthase and dihydropyrimidine dehydrogenase mRNA expression levels: predictors for survival in colorectal cancer patients receiving adjuvant 5-fluorouracil.
    Kornmann M, Schwabe W, Sander S, Kron M, Sträter J, Polat S, Kettner E, Weiser HF, Baumann W, Schramm H, Häusler P, Ott K, Behnke D, Staib L, Beger HG, Link KH.
    Clin Cancer Res; 2003 Sep 15; 9(11):4116-24. PubMed ID: 14519634
    [Abstract] [Full Text] [Related]

  • 15. [Expression of dihydropyrimidine dehydrogenase in primary colorectal cancer and liver metastasis--a relationship between mRNA levels in cancer cells and protein levels in cancerous tissue and effect of 5-fluorouracil].
    Ishibashi K, Sobajima J, Ishiguro T, Ohsawa T, Okada N, Miyazaki T, Yokoyama M, Inokuma S, Ishida H.
    Gan To Kagaku Ryoho; 2009 Nov 15; 36(12):2232-5. PubMed ID: 20037380
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Differential effects of two fluorouracil administration regimens for colorectal cancer.
    Matsusaka S, Yamasaki H, Kitayama Y, Okada T, Maeda S.
    Oncol Rep; 2003 Nov 15; 10(1):109-13. PubMed ID: 12469154
    [Abstract] [Full Text] [Related]

  • 20. [Anti-tumor effects of various interferons-alpha +5-fluorouracil via downregulation of dihydropyrimidine dehydrogenase in hepatoma cells].
    Fan XY, Uchida H, Iwaki K, Kai S, Shibata K, Ohta M, Kitano S.
    Gan To Kagaku Ryoho; 2007 Jun 15; 34(6):957-9. PubMed ID: 17565266
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.